BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38069522)

  • 1. Differential co-expression network analysis elucidated genes associated with sensitivity to farnesyltransferase inhibitor and prognosis of acute myeloid leukemia.
    Kelesoglu N; Kori M; Yilmaz BK; Duru OA; Arga KY
    Cancer Med; 2023 Dec; 12(24):22420-22436. PubMed ID: 38069522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia.
    Braun T; Fenaux P
    Br J Haematol; 2008 May; 141(5):576-86. PubMed ID: 18410457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia.
    Raponi M; Lancet JE; Fan H; Dossey L; Lee G; Gojo I; Feldman EJ; Gotlib J; Morris LE; Greenberg PL; Wright JJ; Harousseau JL; Löwenberg B; Stone RM; De Porre P; Wang Y; Karp JE
    Blood; 2008 Mar; 111(5):2589-96. PubMed ID: 18160667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.
    Pan JQ; Zhang YQ; Wang JH; Xu P; Wang W
    Int J Mol Med; 2017 Mar; 39(3):663-671. PubMed ID: 28204819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.
    Long L; Assaraf YG; Lei ZN; Peng H; Yang L; Chen ZS; Ren S
    Drug Resist Updat; 2020 Sep; 52():100703. PubMed ID: 32599434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
    Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
    Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
    Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
    Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
    Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-based sub-network signatures unveil the potential for acute myeloid leukemia therapy.
    Shi M; Wu M; Pan P; Zhao R
    Mol Biosyst; 2014 Dec; 10(12):3290-7. PubMed ID: 25313005
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Bai H; Zhou M; Zeng M; Han L
    DNA Cell Biol; 2020 Apr; 39(4):700-708. PubMed ID: 32077754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
    Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
    Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
    Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
    Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia.
    Yu X; Chen C; Hu Y; Li K; Zhang Y; Chen Z; Nie D; Gao R; Huang Y; Zhong M; Wang C; Wang S; Zeng Y; Li Y; Zeng C
    Cancer Med; 2023 Apr; 12(7):9055-9067. PubMed ID: 36708053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
    Tian Y; Huang Z; Wang Z; Yin C; Zhou L; Zhang L; Huang K; Zhou H; Jiang X; Li J; Liao L; Yang M; Meng F
    PLoS One; 2014; 9(1):e84150. PubMed ID: 24416201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients.
    Bou Samra E; Klein B; Commes T; Moreaux J
    Oncotarget; 2012 Aug; 3(8):824-32. PubMed ID: 22910040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression pattern and prognostic implication of SALL4 gene in myeloid leukemias: a case-control study.
    Farawela HM; Zawam HM; Al-Wakeel HA; El-Nagdy MH; El-Refaey FA; Abdel-Rahman HA
    Scand J Clin Lab Invest; 2019; 79(1-2):65-70. PubMed ID: 30638095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBC1D16 predicts chemosensitivity and prognosis in adult acute myeloid leukemia (AML) patients.
    Liu H; Chen P; Yang YL; Zhu KW; Wang T; Tang L; Liu YL; Cao S; Zhou G; Zeng H; Zhao XL; Zhang W; Chen XP
    Eur J Pharmacol; 2021 Mar; 895():173894. PubMed ID: 33476656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction network of proteins associated with unfavorable prognosis in acute myeloid leukemia.
    Rendon-Rodriguez JJ; Restrepo-Rodriguez LF; Rothlisberger S
    Acta Biochim Pol; 2020 Dec; 67(4):475-483. PubMed ID: 33284559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-gene signature might predict prognosis in patients with acute myeloid leukemia.
    Zhu X; Zhao Q; Su X; Ke J; Yi Y; Yi J; Lin J; Qian J; Deng Z
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.